Halibrell

Medicinal product

(Invented) name

Halibrell

Active substance (s)

Ranolazinas

Strength

375 mg

Pharmaceutical form

pailginto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C01EB18, Ranolazine

Marketing authorisation holder

Sandoz d.d., Slovėnija

Date of authorisation

2025-03-03

Date of renewal

Documents

5718_5719_5720_Halibrell.docx

5718-5720_pakuotes lapelis_2025-03-03.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

DE/H/7407/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Ranolazinas	375 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
116816	102920	1102920	lizdinė plokštelė	N60		Receptinis	LT/1/25/5718/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-03-03	Registruotas